A Decade of Experience Using mTor Inhibitors in Liver Transplantation

Some studies suggest that Sirolimus (SRL) is associated with an increased risk of death in liver transplant recipients compared to treatment with calcineurin inhibitors (CNIs). We compared patients who received SRL or CNI in the first year after liver transplant. Our database included 688 patients...

Full description

Bibliographic Details
Published in:	Journal of Transplantation
Main Authors:	Jeffrey Campsen, Michael A. Zimmerman, Susan Mandell, Maria Kaplan, Igal Kam
Format:	Article
Language:	English
Published:	Wiley 2011-01-01
Online Access:	http://dx.doi.org/10.1155/2011/913094

Similar Items

Combined Piggyback Technique and Cavoportal Hemitransposition for Liver Transplant
by: Jeffrey Campsen, et al.
Published: (2010-01-01)

The Role of mTOR Inhibitors in Liver Transplantation: Reviewing the Evidence
by: Goran B. Klintmalm, et al.
Published: (2014-01-01)

The Role of mTOR Inhibitors after Liver Transplantation for Hepatocellular Carcinoma
by: Letizia Todeschini, et al.
Published: (2023-06-01)

Direct Anastomosis of the Donor Hepatic Artery to the Supraceliac Aorta without Extension Graft during Adult Liver Transplant in the Era of Extended Criteria Donors: Report of a Case
by: Jeffrey Campsen, et al.
Published: (2010-01-01)

Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients
by: Mathis Wehming, et al.
Published: (2023-02-01)

Cancer and mTOR inhibitors in kidney transplantation recipients
by: Chih-Chin Kao, et al.
Published: (2018-11-01)

mTOR inhibitor reduces nontumour-related death in liver transplantation for hepatocellular carcinoma
by: Lincheng Zhang, et al.
Published: (2024-03-01)

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
by: Zhilin Zou, et al.
Published: (2020-03-01)

Overview of Research into mTOR Inhibitors
by: Beibei Mao, et al.
Published: (2022-08-01)

Targeting ganglioneuromas with mTOR inhibitors
by: Ting Tao, et al.
Published: (2021-01-01)

Donor Complications Following Laparoscopic Compared to Hand-Assisted Living Donor Nephrectomy: An Analysis of the Literature
by: Whitney R. Halgrimson, et al.
Published: (2010-01-01)

Place of mTOR inhibitors in management of BKV infection after kidney transplantation
by: Thomas Jouve, et al.
Published: (2016-01-01)

mTOR Inhibitors as Radiosensitizers in Neuroendocrine Neoplasms
by: Samantha Exner, et al.
Published: (2021-02-01)

mTOR-inhibitors and post-transplant diabetes mellitus: a link still debated in kidney transplantation
by: Simona Granata, et al.
Published: (2023-05-01)

The effect of mTOR inhibitors on respiratory infections in lymphangioleiomyomatosis
by: Andrew M. Courtwright, et al.
Published: (2017-01-01)

Systemic and Nonrenal Adverse Effects Occurring in Renal Transplant Patients Treated with mTOR Inhibitors
by: Gianluigi Zaza, et al.
Published: (2013-01-01)

Cyclopamine and Rapamycin Synergistically Inhibit mTOR Signalling in Mouse Hepatocytes, Revealing an Interaction of Hedgehog and mTor Signalling in the Liver
by: Luise Spormann, et al.
Published: (2020-07-01)

Escaping mTOR inhibition for cancer therapy: Tumor suppressor functions of mTOR
by: Victor H. Villar, et al.
Published: (2017-05-01)

The Role of mTOR Inhibitors for the Treatment of B-Cell Lymphomas
by: Pinelopi Argyriou, et al.
Published: (2012-01-01)

The Cytoprotective and Cytotoxic Functions of Autophagy in Response to mTOR Inhibitors
by: Ahmed M. Elshazly, et al.
Published: (2024-06-01)

mTOR inhibitors in a patient with lupus nephritis; why not?
by: Raquel Berzal, et al.
Published: (2023-12-01)

mTOR inhibitors in a patient with lupus nephritis; why not?
by: Raquel Berzal, et al.
Published: (2023-12-01)

Recent advances and limitations of mTOR inhibitors in the treatment of cancer
by: Eunus S. Ali, et al.
Published: (2022-09-01)

Overcoming cisplatin resistance by mTOR inhibitor in lung cancer
by: Lampidis Theodore, et al.
Published: (2005-07-01)

Exercise, mTOR Activation, and Potential Impacts on the Liver in Rodents
by: Giuliano Moreto Onaka, et al.
Published: (2024-05-01)

The mTOR Inhibitor Rapamycin Counteracts Follicle Activation Induced by Ovarian Cryopreservation in Murine Transplantation Models
by: Jules Bindels, et al.
Published: (2023-08-01)

Genotype-dependent efficacy of a dual PI3K/mTOR inhibitor, NVP-BEZ235, and an mTOR inhibitor, RAD001, in endometrial carcinomas.
by: Keiko Shoji, et al.
Published: (2012-01-01)

mTOR pathway diseases: challenges and opportunities from bench to bedside and the mTOR node
by: Laura Mantoan Ritter, et al.
Published: (2025-05-01)

Genetic Evidence Supporting the Repurposing of mTOR Inhibitors for Reducing BMI
by: Ping Peng, et al.
Published: (2025-03-01)

Effects of mTOR Inhibitors on Components of the Salvador-Warts-Hippo Pathway
by: Julian A. Martinez-Agosto, et al.
Published: (2012-10-01)

Management of mTOR inhibitors oral mucositis: current state of knowledge
by: Calvo Anne Sophie, et al.
Published: (2019-01-01)

Perivascular Epithelioid Cell Tumors (PEComas) Refractory to mTOR Inhibitors
by: San-Chi Chen, et al.
Published: (2014-09-01)

PI3K/Akt/mTOR inhibitors in breast cancer
by: Joycelyn JX Lee, et al.
Published: (2015-12-01)

Advances in the mTOR signaling pathway and its inhibitor rapamycin in epilepsy
by: Wei Zhao, et al.
Published: (2023-06-01)

mTOR inhibitors: A novel class of anti-cancer agents
by: Riaz Haris, et al.
Published: (2012-01-01)

Plasticity and mTOR: Towards Restoration of Impaired Synaptic Plasticity in mTOR-Related Neurogenetic Disorders
by: Tanjala T. Gipson, et al.
Published: (2012-01-01)

AAA + ATPase Thorase inhibits mTOR signaling through the disassembly of the mTOR complex 1
by: George K. E. Umanah, et al.
Published: (2022-08-01)

The mTOR inhibitor Rapamycin protects from premature cellular senescence early after experimental kidney transplantation.
by: Uwe Hoff, et al.
Published: (2022-01-01)

WCN25-2410 LONG-TERM RESULTS OF THE REDUCTION OF EXPOSURE TO CALCINEURIN INHIBITORS ASSOCIATED WITH mTOR INHIBITORS IN KIDNEY TRANSPLANTATION
by: Pablo Raffaele, et al.
Published: (2025-02-01)

WCN25-3086 LONG-TERM RESULTS OF THE REDUCTION OF EXPOSURE TO CALCINEURIN INHIBITORS ASSOCIATED WITH mTOR INHIBITORS IN KIDNEY TRANSPLANTATION
by: Pablo Raffaele, et al.
Published: (2025-02-01)